Teladoc's long-time CEO is leav­ing

(This sto­ry is from our new Health Tech newslet­ter. If you’d like to sign up, just click here.) 

Teladoc Health’s CEO Ja­son Gore­vic is step­ping down, the com­pa­ny said on Fri­day, as the tele­health gi­ant’s stock dropped to an all-time low in eight years.

Teladoc’s stock dropped to around $14 per share when mar­kets opened Fri­day, the low­est price since 2016.

Gore­vic stepped in­to his role as CEO in 2009. He over­saw Teladoc’s IPO in 2015 and its ac­qui­si­tion of Livon­go in 2020. The com­pa­ny has strug­gled to make its ac­qui­si­tion of Livon­go prof­itable, re­port­ing a loss of $14 bil­lion on the deal in 2022.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER